TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioperm AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0 | |
| Financial expenses |
2
|
5 | |
| Earnings before taxes |
-17
|
-28 | |
| EBITDA |
-25
|
-23 | |
| Total assets |
507
|
540 | |
| Current assets |
237
|
274 | |
| Current liabilities |
11
|
4 | |
| Equity capital |
494
|
522 | |
| - share capital |
9
|
9 | |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.4%
|
96.7% | |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-3.0%
|
-4.3% | |
| Current ratio |
2154.5%
|
6850.0% | |
| Return on equity (ROE) |
-3.4%
|
-5.4% | |
| Change turnover |
0
|
-124 | |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.